+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fluoxetine decreased depressive symptoms in children and adolescents with non-psychotic major depressive disorder



Fluoxetine decreased depressive symptoms in children and adolescents with non-psychotic major depressive disorder



Evidence-Based Mental Health 1(2): 49-49




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062703060

Download citation: RISBibTeXText

DOI: 10.1136/ebmh.1.2.49


Related references

The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder. Nordic Journal of Psychiatry 63(5): 420-425, 2012

Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder. Journal of Clinical Psychiatry 65(12): 1654-9; Quiz 1760-1, 2005

Cognitive impairment in major depressive disorder and severe depressive episode with psychotic symptoms. European Psychiatry 41: S143-S144, 2017

Fluoxetine plus cognitive behavioural therapy improves symptoms of major depressive disorder in adolescents. Evidence-Based Mental Health 8(1): 10, 2005

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. Journal of Clinical Psychopharmacology 22(5): 474-480, 2002

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents. Journal of Child and Adolescent Psychopharmacology 14(3): 412-417, 2005

Continuing fluoxetine treatment may delay relapse in children and adolescents with major depressive disorder. Evidence-Based Mental Health 8(2): 37, 2005

Time Spent with Parents Predicts Change in Depressive Symptoms in Adolescents with Major Depressive Disorder. Journal of Abnormal Child Psychology 2019, 2019

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder. Journal of Child and Adolescent Psychopharmacology 28(1): 36-46, 2017

Escalation to Major Depressive Disorder among adolescents with subthreshold depressive symptoms: evidence of distinct subgroups at risk. Journal of Affective Disorders 158: 133-138, 2015

Sertraline improves symptoms in children and adolescents with major depressive disorder. Evidence-Based Mental Health 7(1): 10, 2004

Does major depressive disorder with somatic delusions constitute a distinct subtype of major depressive disorder with psychotic features?. Journal of Affective Disorders 112(1-3): 250-255, 2008

An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses. Journal of Clinical Psychiatry 63(12): 1164-1170, 2003

A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine. Journal of Child and Adolescent Psychopharmacology 20(5): 431-439, 2011

Observational measurement of symptoms responsive to treatment of major depressive disorder in children and adolescents. Journal of Nervous and Mental Disease 180(10): 639-643, 1992